Cell-to-cell variability in PI3K protein level regulates PI3K-AKT pathway activity in cell populations.
BACKGROUND
Cell-to-cell variability in populations has been widely observed in mammalian cells. This heterogeneity can result from random stochastic events or can be deliberately maintained through regulatory processes. In the latter case, heterogeneity should confer a selective advantage that benefits the entire population.


RESULTS
Using multicolor flow cytometry, we have uncovered robust heterogeneity in phosphoinositide 3-kinase (PI3K) activity in MCF10A cell populations, which had been previously masked by techniques that only measure population averages. We show that AKT activity is bimodal in response to EGF stimulation and correlates with PI3K protein level, such that only cells with high PI3K protein can activate AKT. We further show that heterogeneity in PI3K protein levels is invariably maintained in cell populations through a degradation/resynthesis cycle that can be regulated by cell density.


CONCLUSIONS
Given that the PI3K pathway is one of the most frequently upregulated pathways in cancer, we propose that heterogeneity in PI3K activity is beneficial to normal tissues by restricting PI3K activation to only a subset of cells. This may serve to protect the population as a whole from overactivating the pathway, which can lead to cellular senescence or cancer. Consistent with this, we show that oncogenic mutations in p110α (H1047R and E545K) partially evade this negative regulation, resulting in increased AKT activity in the population.
Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Tina L
TL
Yuan
Gerburg
G
Wulf
Laura
L
Burga
Lewis C
LC
Cantley
D002450:Cell Communication; D002460:Cell Line; D058543:Class Ia Phosphatidylinositol 3-Kinase / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005434:Flow Cytometry; D006801:Humans; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction
D004815:Epidermal Growth Factor; D019869:Phosphatidylinositol 3-Kinases; D058543:Class Ia Phosphatidylinositol 3-Kinase; D051057:Proto-Oncogene Proteins c-akt
Curr Opin Chem Biol. 2009 Dec;13(5-6):556-61
19833543
Cancer Res. 2005 Dec 1;65(23):10992-1000
16322248
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7
15647370
Mol Cell Biol. 2005 Mar;25(5):1596-607
15713620
J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45
9701363
PLoS Biol. 2009 Jul;7(7):e1000149
19582141
Cancer Cell. 2005 Jun;7(6):561-73
15950905
Science. 2008 Dec 5;322(5907):1511-6
19023046
Science. 2004 Sep 10;305(5690):1622-5
15308767
Nat Rev Cancer. 2009 Aug;9(8):550-62
19629070
Cell. 2010 Apr 2;141(1):69-80
20371346
Cancer Cell. 2009 Aug 4;16(2):115-25
19647222
Cancer Res. 2010 Feb 1;70(3):1164-72
20103642
Cell. 2002 Oct 4;111(1):29-40
12372298
J Clin Oncol. 2010 Feb 20;28(6):1075-83
20085938
J Biol Chem. 2003 Nov 28;278(48):48453-66
14504291
Development. 2009 Dec;136(23):3853-62
19906852
Methods. 2003 Jul;30(3):256-68
12798140
Oncogene. 2008 Sep 18;27(41):5497-510
18794884
Science. 2002 May 31;296(5573):1655-7
12040186
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12111-6
17626182
Nature. 2005 Aug 4;436(7051):725-30
16079851
Mol Cancer Ther. 2009 Aug;8(8):2204-10
19671762
J Cell Biol. 2005 Aug 1;170(3):455-64
16043515
Cancer Cell. 2008 Aug 12;14(2):111-22
18656424
Nature. 2008 May 22;453(7194):544-7
18497826
Nature. 2009 May 21;459(7245):428-32
19363473
J Clin Invest. 2010 Mar;120(3):681-93
20197621
Mol Cell Biol. 2007 Apr;27(8):2830-40
17283057
Cell. 2008 Oct 17;135(2):216-26
18957198
Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17
20578106
Nature. 2007 Dec 20;450(7173):1230-4
18097409
Br J Cancer. 2009 Apr 21;100(8):1267-76
19319133
Nat Genet. 2008 Apr;40(4):471-5
18362885
Science. 1998 May 8;280(5365):895-8
9572732
Mol Cancer Ther. 2008 Jul;7(7):1851-63
18606717
Mol Cancer Ther. 2009 Jul;8(7):1725-38
19584227
J Cell Biol. 2003 Oct 27;163(2):315-26
14568991
Mol Cell Biol. 2002 Feb;22(3):965-77
11784871